As more and more vaccines are approved by regulators, countries are facing a new question: which ones should be given to the most vulnerable? Several European countries say they will not administer the AstraZeneca-Oxford vaccine to the elderly, citing a lack of data about its efficacy in that age range. Should Australia restrict its use to the young?